Atlas Trials

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease

Clinical trial NCT00925587 · COMPLETED

Trial details

NCT number
NCT00925587
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
AnemiaChronic Kidney Disease
Start date
2009-06-01
Primary completion
2012-04-01
Enrollment
358

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.